Preventing Illness While on GLP-1 Therapy While you cant avoid every cold and flu, certain strategies help minimize your risk and maintain your immune system health
What You Need to Know About Semaglutide Semaglutide is a GLP-1 receptor agonist sanctioned by the FDA for adults managing chronic weight conditions, including obesity and overweight cases linked with comorbidities
If you'd like to learn more about how GLP-1 works throughout the body and why it's become such an important focus of metabolic health research, read our complete guide to What Is GLP-1
N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia
If you want the wider picture of what to expect across all the common effects, we cover it in our guide to managing GLP-1 side effects
According to guidance issued jointly by the American Academy of Ophthalmology (AAO) and the North American Neuro-Ophthalmology Society (NANOS), the recently published study identified a potential association between semaglutide and NAION but did not establish that the medication causes the condition